Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

69 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis

NCT04626921

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +9 more
Locations
  • Sydney Brain Mind Centre Camperdown, New South Wales, Australia
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Princess Alexandra Hospital Woolloongabba, Queensland, Australia
  • Menzies Institute for Medical Research Hobart, TAZ, Australia
View Trial Details
Completed

A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

NCT02549170

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Arizona Neuromuscular Research Center Phoenix, Arizona, United States
  • HonorHealth Neurology Scottsdale, Arizona, United States
  • University of California-Irvine Orange, California, United States
View all 83 locations
View Trial Details
Completed

An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients

NCT02003144

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +26 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • The Research Center of Southern California Oceanside, California, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Miami McKnight Brain Institute Miami, Florida, United States
View all 69 locations
View Trial Details
Completed

N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders

NCT02200770

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +10 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Sacramento, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Aurora, Colorado, United States
View all 98 locations
View Trial Details

Related conditions